Enhancing QOL in Cancer Patients: An Observational Study on the Incidence and Severity of Platinum-Induced Peripheral Neuropathy at a Single Cancer Centre in Chennai

Background and objectives: Chemotherapy-induced peripheral neuropathy (CIPN) is a persistent adverse effect of agents like taxanes, platinum drugs, etc. This study focuses on platinum drugs and aims to compare platinum-based regimens, regarding the incidence and severity of platinum-induced peripheral neuropathy (PIPN), to identify those with higher neurotoxic potential. A secondary objective is to assess patient-specific risk factors to improve analysis accuracy.